{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:30:57Z","timestamp":1790879457354,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Complementary and alternative medicine (CAM) is frequently used in the general population, yet only limited data are available regarding the prevalence of these medications in patients with chronic kidney disease (CKD). Hence, our study aimed to explore the prevalence and types of CAM in Taiwanese patients with CKD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional questionnaire survey was conducted by face-to-face interview of 275 pre-dialysis patients without dialysis treatment or kidney transplant at an outpatient nephrology clinic in Taiwan from March 2021 to June 2023. The study outcomes were the prevalence of CAM, CAM types, reasons for using CAM, and sources of information about CAM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 128 patients (46.5%) were using CAM, but no significant differences from non-CAM users in the various CKD stages (<jats:italic>p<\/jats:italic>\u2009=\u20090.156) were found. CAM usage was high in the age range of 20\u201360\u00a0years and duration of CKD\u2009\u2264\u20095\u00a0years (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). The most commonly used type of CAM was nutritional approaches (79.7%), followed by other complementary health approaches (26.6%). The most commonly utilized modalities of CAM were vitamins and minerals (38.3%), and only 27.1% of patients disclosed their CAM use to their physicians. The most common sources of information about CAM were family and friends, cited by 66% of the participants. Health promotion and a proactive attitude were reported by 40% of users as the reasons for using CAM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present study provides data on the CAM usage among CKD patients and adds to the increasing evidence on CAM use. Because some of these practices have safety concerns, better education from healthcare providers on the risks and benefits of CAM therapy is needed by CKD patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-023-04311-2","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T09:02:23Z","timestamp":1704186143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence and varieties of complementary and alternative medicine usage among individuals with pre-dialysis chronic kidney disease in Taiwan: an investigative cross-sectional analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Ming-Yen","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chuen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Chung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Ying","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Tang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"4311_CR1","unstructured":"International Society of Nephrology. [https:\/\/www.theisn.org\/edigest-nov-2021\/]. Accessed 1 Dec 2023."},{"issue":"3","key":"4311_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000491708","volume":"140","author":"MH Tsai","year":"2018","unstructured":"Tsai MH, Hsu CY, Lin MY, Yen MF, Chen HH, Chiu YH, Hwang SJ. Incidence, Prevalence, and Duration of Chronic Kidney Disease in Taiwan: Results from a Community-Based Screening Program of 106,094 Individuals. Nephron. 2018;140(3):175\u201384.","journal-title":"Nephron"},{"issue":"1","key":"4311_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.ajkd.2016.10.001","volume":"69","author":"S Sharief","year":"2017","unstructured":"Sharief S, Hsu CY. The Transition From the Pre-ESRD to ESRD Phase of CKD: Much Remains to Be Learned. Am J Kidney Dis. 2017;69(1):8\u201310.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"4311_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1053\/ajkd.1998.v31.pm9506677","volume":"31","author":"GT Obrador","year":"1998","unstructured":"Obrador GT, Pereira BJ. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis. 1998;31(3):398\u2013417.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"4311_CR5","doi-asserted-by":"publisher","first-page":"e0198387","DOI":"10.1371\/journal.pone.0198387","volume":"13","author":"MY Lin","year":"2018","unstructured":"Lin MY, Cheng LJ, Chiu YW, Hsieh HM, Wu PH, Lin YT, Wang SL, Jian FX, Hsu CC, Yang SA, et al. Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population-based study. PLoS ONE. 2018;13(6):e0198387.","journal-title":"PLoS ONE"},{"issue":"1","key":"4311_CR6","doi-asserted-by":"publisher","first-page":"22602","DOI":"10.1038\/s41598-021-01860-9","volume":"11","author":"CL Chou","year":"2021","unstructured":"Chou CL, Chung CH, Chiu HW, Liao CT, Wu CC, Hsu YH, Chien WC. Association of pre-ESRD care education with patient outcomes in a 10-year longitudinal study of patients with CKD stages 3\u20135 in Taiwan. Sci Rep. 2021;11(1):22602.","journal-title":"Sci Rep"},{"key":"4311_CR7","doi-asserted-by":"crossref","unstructured":"Lin MY, Chang MY, Wu PY, Wu PH, Lin MH, Hsu CC, Chang JM, Hwang SJ, Chiu YW. Multidisciplinary care program in pre-end-stage kidney disease from 2010 to 2018 in Taiwan. J Formos Med Assoc. 2022; 121 Suppl 1:S64-s72.","DOI":"10.1016\/j.jfma.2021.12.008"},{"issue":"1","key":"4311_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/ckj\/sfu128","volume":"8","author":"S Fishbane","year":"2015","unstructured":"Fishbane S, Hazzan AD, Halinski C, Mathew AT. Challenges and opportunities in late-stage chronic kidney disease. Clin Kidney J. 2015;8(1):54\u201360.","journal-title":"Clin Kidney J"},{"issue":"7\u20138","key":"4311_CR9","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1365-2702.2010.03498.x","volume":"20","author":"AD Akyol","year":"2011","unstructured":"Akyol AD, Yildirim Y, Toker E, Yavuz B. The use of complementary and alternative medicine among chronic renal failure patients. J Clin Nurs. 2011;20(7\u20138):1035\u201343.","journal-title":"J Clin Nurs"},{"issue":"1","key":"4311_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12906-018-2342-2","volume":"18","author":"J Mbizo","year":"2018","unstructured":"Mbizo J, Okafor A, Sutton MA, Leyva B, Stone LM, Olaku O. Complementary and alternative medicine use among persons with multiple chronic conditions: results from the 2012 National Health Interview Survey. BMC Complement Altern Med. 2018;18(1):281.","journal-title":"BMC Complement Altern Med"},{"issue":"8","key":"4311_CR11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s11655-016-2748-y","volume":"24","author":"K Peltzer","year":"2018","unstructured":"Peltzer K, Pengpid S. Prevalence and Determinants of Traditional, Complementary and Alternative Medicine Provider Use among Adults from 32 Countries. Chin J Integr Med. 2018;24(8):584\u201390.","journal-title":"Chin J Integr Med"},{"key":"4311_CR12","doi-asserted-by":"publisher","first-page":"102652","DOI":"10.1016\/j.ctim.2020.102652","volume":"57","author":"SWF Chu","year":"2021","unstructured":"Chu SWF, Yeam CT, Low LL, Tay WY, Foo WYM, Seng JJB. The role of mind-body interventions in pre-dialysis chronic kidney disease and dialysis patients - A systematic review of literature. Complement Ther Med. 2021;57:102652.","journal-title":"Complement Ther Med"},{"key":"4311_CR13","doi-asserted-by":"publisher","first-page":"102609","DOI":"10.1016\/j.ctim.2020.102609","volume":"56","author":"CT Yeam","year":"2021","unstructured":"Yeam CT, Yo TE, Tan YLC, Liew A, Seng JJB. Complementary and alternative medicine therapies for uremic pruritus - A systematic review of randomized controlled trials. Complement Ther Med. 2021;56:102609.","journal-title":"Complement Ther Med"},{"key":"4311_CR14","doi-asserted-by":"publisher","first-page":"101593","DOI":"10.1016\/j.ctcp.2022.101593","volume":"48","author":"SWF Chu","year":"2022","unstructured":"Chu SWF, Ng WJ, Yeam CT, Khan RQ, Low LL, Quah JHM, Foo WYM, Seng JJB. Manipulative and body-based methods in chronic kidney disease patients: A systematic review of randomized controlled trials. Complement Ther Clin Pract. 2022;48:101593.","journal-title":"Complement Ther Clin Pract"},{"issue":"12","key":"4311_CR15","first-page":"e32874","volume":"14","author":"WY Teo","year":"2022","unstructured":"Teo WY, Chu SWF, Chow LY, Yeam CT, Low LL, Quah JHM, Foo M, Seng JJB. Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature. Cureus. 2022;14(12):e32874.","journal-title":"Cureus"},{"key":"4311_CR16","doi-asserted-by":"crossref","unstructured":"White A, Boon H, Alraek T, Lewith G, Liu J, Norheim A, Steinsbekk A, Yamashita H, F\u00f8nneb\u00f8 V. Reducing the risk of complementary and alternative medicine (CAM): Challenges and priorities. Eur J Integr Med. 2013;6(4):404\u20138.","DOI":"10.1016\/j.eujim.2013.09.006"},{"issue":"6","key":"4311_CR17","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/ki.2015.226","volume":"88","author":"MY Lin","year":"2015","unstructured":"Lin MY, Chiu YW, Chang JS, Lin HL, Lee CT, Chiu GF, Kuo MC, Wu MT, Chen HC, Hwang SJ. Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease. Kidney Int. 2015;88(6):1365\u201373.","journal-title":"Kidney Int"},{"key":"4311_CR18","doi-asserted-by":"publisher","first-page":"153473542098391","DOI":"10.1177\/1534735420983910","volume":"19","author":"CY Chin","year":"2020","unstructured":"Chin CY, Chen YH, Wu SC, Liu CT, Lee YF, Tsai MY. Complementary and Alternative Medicine Use in Breast Cancer Patients at a Medical Center in Taiwan: A Cross-Sectional Study. Integr Cancer Ther. 2020;19:1534735420983910.","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"4311_CR19","first-page":"85","volume":"32","author":"M-Y Chang","year":"2013","unstructured":"Chang M-Y, Liu C-Y, Chu M-C, Wu T-M, Chen M-L, Chu M-L. Conditions for the use of complementary and alternative medicine in Taiwan: a nationwide survey analysis for 2011. Taiwan Gong Gong Wei Sheng Za Zhi. 2013;32(1):85\u201399.","journal-title":"Taiwan Gong Gong Wei Sheng Za Zhi"},{"key":"4311_CR20","doi-asserted-by":"publisher","first-page":"2809875","DOI":"10.1155\/2016\/2809875","volume":"2016","author":"DA Erku","year":"2016","unstructured":"Erku DA. Complementary and Alternative Medicine Use and Its Association with Quality of Life among Cancer Patients Receiving Chemotherapy in Ethiopia: A Cross-Sectional Study. Evid Based Complement Alternat Med. 2016;2016:2809875.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"4311_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1053\/j.jrn.2008.08.008","volume":"19","author":"R Nowack","year":"2009","unstructured":"Nowack R, Ball\u00e9 C, Birnkammer F, Koch W, Sessler R, Birck R. Complementary and alternative medications consumed by renal patients in southern Germany. J Renal Nutr. 2009;19(3):211\u20139.","journal-title":"J Renal Nutr"},{"key":"4311_CR22","unstructured":"Complementary, alternative, or integrative health: what's in a name (n.d.) [https:\/\/www.nccih.nih.gov\/health\/complementary-alternative-or-integrative-health-whats-in-a-name]. Accessed 1 Dec 2023."},{"issue":"6","key":"4311_CR23","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1053\/j.jrn.2015.04.009","volume":"25","author":"NA Osman","year":"2015","unstructured":"Osman NA, Hassanein SM, Leil MM, NasrAllah MM. Complementary and Alternative Medicine Use Among Patients With Chronic Kidney Disease and Kidney Transplant Recipients. J Renal Nutr. 2015;25(6):466\u201371.","journal-title":"J Renal Nutr"},{"key":"4311_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.17576\/MH.2019.1402.20","volume":"14","author":"AS Muhammad Yusuf","year":"2019","unstructured":"Muhammad Yusuf AS, Abdul Halim AG, Shamsul Azhar S. The Use of Complementary and Alternative Medicine among Malaysian Chronic Kidney Disease Patients. Med Health. 2019;14:219\u201334.","journal-title":"Med Health"},{"issue":"3","key":"4311_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/nhs.12609","volume":"21","author":"HO Jeon","year":"2019","unstructured":"Jeon HO, Kim BH, Kim O. Illness uncertainty and complementary and alternative medicine use in patients undergoing hemodialysis. Nurs Health Sci. 2019;21(3):375\u201381.","journal-title":"Nurs Health Sci"},{"issue":"1","key":"4311_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1440-1797.2009.01154.x","volume":"15","author":"SY Wei","year":"2010","unstructured":"Wei SY, Chang YY, Mau LW, Lin MY, Chiu HC, Tsai JC, Huang CJ, Chen HC, Hwang SJ. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs. Nephrology (Carlton). 2010;15(1):108\u201315.","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"4311_CR27","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/ki.2015.118","volume":"88","author":"H Hao","year":"2015","unstructured":"Hao H, Lovasik BP, Pastan SO, Chang HH, Chowdhury R, Patzer RE. Geographic variation and neighborhood factors are associated with low rates of pre-end-stage renal disease nephrology care. Kidney Int. 2015;88(3):614\u201321.","journal-title":"Kidney Int"},{"issue":"3","key":"4311_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/ndt\/gfs469","volume":"28","author":"YR Chen","year":"2013","unstructured":"Chen YR, Yang Y, Wang SC, Chiu PF, Chou WY, Lin CY, Chang JM, Chen TW, Ferng SH, Lin CL. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study. Nephrol Dial Transplant. 2013;28(3):671\u201382.","journal-title":"Nephrol Dial Transplant"},{"key":"4311_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/654109","volume":"2013","author":"GS Birdee","year":"2013","unstructured":"Birdee GS, Phillips RS, Brown RS. Use of Complementary and Alternative Medicine among Patients with End-Stage Renal Disease. Evid Based Complement Alternat Med. 2013;2013: 654109.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"4311_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/1319-2442.252909","volume":"30","author":"LR Castelino","year":"2019","unstructured":"Castelino LR, Nayak-Rao S, Shenoy MP. Prevalence of use of complementary and alternative medicine in chronic kidney disease: A cross-sectional single-center study from South India. Saudi J Kidney Dis Transpl. 2019;30(1):185\u201393.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"1","key":"4311_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ctim.2005.02.003","volume":"13","author":"D Barraco","year":"2005","unstructured":"Barraco D, Valencia G, Riba AL, Nareddy S, Draus CB, Schwartz SM. Complementary and alternative medicine (CAM) use patterns and disclosure to physicians in acute coronary syndromes patients. Complement Ther Med. 2005;13(1):34\u201340.","journal-title":"Complement Ther Med"},{"key":"4311_CR32","doi-asserted-by":"crossref","unstructured":"Shamsuddin N, Karuppannan M, Hafiz Wan Md Adnan WA, Farooqui M, Gnanasan S. Pattern of complementary and alternative medicine (CAM) use among patients with chronic kidney disease. Complement Ther Clin Pract. 2019; 37:86-92.","DOI":"10.1016\/j.ctcp.2019.09.003"},{"issue":"12","key":"4311_CR33","first-page":"835","volume":"159","author":"A Qaseem","year":"2013","unstructured":"Qaseem A, Hopkins RH Jr, Sweet DE, Starkey M, Shekelle P. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013;159(12):835\u201347.","journal-title":"Ann Intern Med"},{"issue":"1","key":"4311_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12882-021-02618-1","volume":"23","author":"LA Baker","year":"2022","unstructured":"Baker LA, March DS, Wilkinson TJ, Billany RE, Bishop NC, Castle EM, Chilcot J, Davies MD, Graham-Brown MPM, Greenwood SA, et al. Clinical practice guideline exercise and lifestyle in chronic kidney disease. BMC Nephrol. 2022;23(1):75.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4311_CR35","first-page":"53","volume":"28","author":"K-C Lin","year":"2009","unstructured":"Lin K-C, Chen M-L, Yeh M-L, Hsu C-H, Chen Y-L, Chou P. Prevalence, Pattern, and Predictors of Use of Complementary and Alternative Medicine in Taiwan. Taiwan J Public Health. 2009;28(1):53\u201368.","journal-title":"Taiwan J Public Health"},{"issue":"2","key":"4311_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/HNP.0000000000000071","volume":"29","author":"ML Yeh","year":"2015","unstructured":"Yeh ML, Lin KC, Chen HH, Wang YJ, Huang YC. Use of traditional medicine and complementary and alternative medicine in Taiwan: a multilevel analysis. Holist Nurs Pract. 2015;29(2):87\u201395.","journal-title":"Holist Nurs Pract"},{"issue":"3","key":"4311_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ctim.2014.03.001","volume":"22","author":"MY Chang","year":"2014","unstructured":"Chang MY, Liu CY, Chen HY. Changes in the use of complementary and alternative medicine in Taiwan: a comparison study of 2007 and 2011. Complement Ther Med. 2014;22(3):489\u201399.","journal-title":"Complement Ther Med"},{"key":"4311_CR38","doi-asserted-by":"crossref","unstructured":"Chang HY, Wallis M, Tiralongo E. Use of Complementary and Alternative Medicine among People with Type 2 Diabetes in Taiwan: A Cross-Sectional Survey. Evid Based Complement Alternat Med. 2011;2011:983792.","DOI":"10.1155\/2011\/983792"},{"issue":"2\u20133","key":"4311_CR39","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jad.2008.03.010","volume":"111","author":"MC Hsu","year":"2008","unstructured":"Hsu MC, Creedy D, Moyle W, Venturato L, Tsay SL, Ouyang WC. Use of Complementary and Alternative Medicine among adult patients for depression in Taiwan. J Affect Disord. 2008;111(2\u20133):360\u20135.","journal-title":"J Affect Disord"},{"key":"4311_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1472-6882-13-153","volume":"13","author":"M Tangkiatkumjai","year":"2013","unstructured":"Tangkiatkumjai M, Boardman H, Praditpornsilpa K, Walker DM. Prevalence of herbal and dietary supplement usage in Thai outpatients with chronic kidney disease: a cross-sectional survey. BMC Complement Altern Med. 2013;13:153.","journal-title":"BMC Complement Altern Med"},{"key":"4311_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/IJNRD.S240705","volume":"13","author":"L AlAnizy","year":"2020","unstructured":"AlAnizy L, AlMatham K, Al Basheer A, AlFayyad I. Complementary and Alternative Medicine Practice Among Saudi Patients with Chronic Kidney Disease: A Cross-Sectional Study. Int J Nephrol Renov Dis. 2020;13:11\u20138.","journal-title":"Int J Nephrol Renov Dis"},{"key":"4311_CR42","doi-asserted-by":"crossref","unstructured":"Koithan M. Let\u2019s Talk about Complementary and Alternative Therapies. J Nurse Pract. 2009;5(3):214\u20135.","DOI":"10.1016\/j.nurpra.2008.12.011"},{"issue":"2","key":"4311_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pec.2009.07.038","volume":"79","author":"P Schofield","year":"2010","unstructured":"Schofield P, Diggens J, Charleson C, Marigliani R, Jefford M. Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns. 2010;79(2):143\u201351.","journal-title":"Patient Educ Couns"},{"key":"4311_CR44","unstructured":"JDK, SGM. Nutritional management of renal disease. In. Edited by JDK, SGM. Baltimore: Williams and Wilkins; 2004."},{"key":"4311_CR45","doi-asserted-by":"crossref","unstructured":"Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero J-J, Chan W, Fouque D, Friedman AN, Ghaddar S, Goldstein-Fuchs DJ, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis. 2020;76(3):S1\u2013107.","DOI":"10.1053\/j.ajkd.2020.05.006"},{"issue":"1","key":"4311_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/j.jrn.2010.11.004","volume":"21","author":"GJ Handelman","year":"2011","unstructured":"Handelman GJ, Levin NW. Guidelines for vitamin supplements in chronic kidney disease patients: what is the evidence? J Renal Nutr. 2011;21(1):117\u20139.","journal-title":"J Renal Nutr"},{"issue":"3","key":"4311_CR47","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1046\/j.1523-1755.2003.00815.x","volume":"63","author":"AC Baxmann","year":"2003","unstructured":"Baxmann AC, De OGMC, Heilberg IP. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int. 2003;63(3):1066\u201371.","journal-title":"Kidney Int"},{"key":"4311_CR48","doi-asserted-by":"crossref","unstructured":"Messa P. Dietary Habits, Vitamin and Mineral Supplements in Patients with Chronic Kidney Disease (CKD). Nutrients. 2020;12(12):3817.","DOI":"10.3390\/nu12123817"},{"issue":"1","key":"4311_CR49","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12882-021-02351-9","volume":"22","author":"S Fazelian","year":"2021","unstructured":"Fazelian S, Moradi F, Agah S, Hoseini A, Heydari H, Morvaridzadeh M, Omidi A, Pizarro AB, Ghafouri A, Heshmati J. Effect of omega-3 fatty acids supplementation on cardio-metabolic and oxidative stress parameters in patients with chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol. 2021;22(1):160.","journal-title":"BMC Nephrol"},{"issue":"2","key":"4311_CR50","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.clnu.2019.02.041","volume":"39","author":"VM Saglimbene","year":"2020","unstructured":"Saglimbene VM, Wong G, van Zwieten A, Palmer SC, Ruospo M, Natale P, Campbell K, Teixeira-Pinto A, Craig JC, Strippoli GFM. Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials. Clin Nutr. 2020;39(2):358\u201368.","journal-title":"Clin Nutr"},{"key":"4311_CR51","doi-asserted-by":"crossref","unstructured":"Martello E, Perondi F, Bruni N, Bisanzio D, Meineri G, Lippi I. Chronic Kidney Disease and Dietary Supplementation: Effects on Inflammation and Oxidative Stress. Vet Sci. 2021;8(11):277.","DOI":"10.3390\/vetsci8110277"},{"key":"4311_CR52","doi-asserted-by":"crossref","unstructured":"Lin PC, Chou CL, Ou SH, Fang TC, Chen JS. Systematic Review of Nutrition Supplements in Chronic Kidney Diseases: A GRADE Approach. Nutrients. 2021;13(2):469.","DOI":"10.3390\/nu13020469"},{"issue":"1","key":"4311_CR53","first-page":"41","volume":"25","author":"T-H Yang","year":"2014","unstructured":"Yang T-H, Chen H-Y, Yang S-H, Lin Y-H, Fang J-T, Hung C-C, Chen J-L. Utilization Pattern for Traditional Chinese Medicine among Late Stage Chronic Kidney Disease Patients: A Hospital-Based Cross-sectional Study. J Chinese Med. 2014;25(1):41\u201358.","journal-title":"J Chinese Med"},{"issue":"9888","key":"4311_CR54","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260\u201372.","journal-title":"Lancet"},{"issue":"5","key":"4311_CR55","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1053\/j.ajkd.2007.02.259","volume":"49","author":"JY Guh","year":"2007","unstructured":"Guh JY, Chen HC, Tsai JF, Chuang LY. Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan. Am J Kidney Dis. 2007;49(5):626\u201333.","journal-title":"Am J Kidney Dis"},{"key":"4311_CR56","first-page":"9953986","volume":"2021","author":"YW Liu","year":"2021","unstructured":"Liu YW, Hsu YT, Lee WC, Tsai MY. Review of Traditional Chinese Medicines for Common Complications Related to Hemodialysis: An Evidence-Based Perspective. Evid Based Complement Alternat Med. 2021;2021:9953986.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"4311_CR57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ypmed.2012.06.003","volume":"55","author":"CF Hsieh","year":"2012","unstructured":"Hsieh CF, Huang SL, Chen CL, Chen WT, Chang HC, Wu ML, Yang CC. Increased risk of chronic kidney disease among users of non-prescribed Chinese herbal medicine in Taiwan. Prev Med. 2012;55(2):155\u20139.","journal-title":"Prev Med"},{"key":"4311_CR58","doi-asserted-by":"publisher","first-page":"5080764","DOI":"10.1155\/2018\/5080764","volume":"2018","author":"W Chen","year":"2018","unstructured":"Chen W, Chen HY, Yang YH, Yang SH, Yang CW, Wu YH, Chen JL. An Investigation of the Prescription Patterns of Chinese Herbal Products for Chronic Glomerulonephritis Patients: A Hospital-Based Cross-Sectional Study. Evid Based Complement Alternat Med. 2018;2018:5080764.","journal-title":"Evid Based Complement Alternat Med"},{"key":"4311_CR59","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jep.2014.08.029","volume":"156","author":"PC Hsu","year":"2014","unstructured":"Hsu PC, Tsai YT, Lai JN, Wu CT, Lin SK, Huang CY. Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: a population-based case control study. J Ethnopharmacol. 2014;156:358\u201364.","journal-title":"J Ethnopharmacol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-04311-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-023-04311-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-04311-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T09:03:27Z","timestamp":1704186207000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-023-04311-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4311"],"URL":"https:\/\/doi.org\/10.1186\/s12906-023-04311-2","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"11 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee at Kaohsiung Chang Gung Memorial Hospital (registration number 202100097B0) as well as each research facility. This study was performed in accordance with the tenets set forth in the Declaration of Helsinki. All enrolled patients provided informed written consent prior to participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}